Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belgrade, M. J.
Right arrow Articles by Ruiz, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belgrade, M. J.
Right arrow Articles by Ruiz, E.
NEUROLOGY 1989;39:590
© 1989 American Academy of Neurology

Comparison of single dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache

M. J. Belgrade, MD, L. J. Ling, MD, M. B. Schleevogt, MD, M. G. Ettinger, MD and E. Ruiz, MD

Department of Neurology, Hennepin County Medical Center and University of Minnesota, Minneapolis, MN (Drs. Belgrade and Ettinger)
Department of Emergency Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, MN (Drs. Ling, Schleevogt, and Ruiz).

We treated 64 emergency room patients with a primary vascular headache with dihydroergotamine (DHE), meperidine, or butorphanol. Post-treatment pain scores were lowest in the DHE group (p <0.01). Eight of 21 patients receiving DHE had greater than 90% reduction in pain compared with three of 19 patients receiving butorphanol and none of 22 receiving meperidine.

Address correspondence and reprint requests to Dr. Belgrade, Department of Neurology, Hennaing County Medical Center, 701 Park Avenue S., Minneapolis, MN 55415.

Received July 26,1988. Accepted for publication in final form October 17, 1988.




This article has been cited by other articles:


Home page
 Postgrad. Med. J.Home page
I. Parlak, B. Erdur, M. Parlak, A. Ergin, I. Turkcuer, O. Tomruk, C. Ayrik, and N. Ergin
Intravenous administration of metoclopramide by 2 min bolus vs 15 min infusion: does it affect the improvement of headache while reducing the side effects?
Postgrad. Med. J., October 1, 2007; 83(984): 664 - 668.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
I. Colman, M. D Brown, G. D Innes, E. Grafstein, T. E Roberts, and B. H Rowe
Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials
BMJ, December 11, 2004; 329(7479): 1369 - 1373.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
I. Colman, A. Rothney, S. C. Wright, B. Zilkalns, and B. H. Rowe
Use of narcotic analgesics in the emergency department treatment of migraine headache
Neurology, May 25, 2004; 62(10): 1695 - 1700.
[Abstract] [Full Text] [PDF]

Home page
 Emerg. Med. J.Home page
M Cicek, O Karcioglu, I Parlak, V Ozturk, O Duman, M Serinken, and M Guryay
Prospective, randomised, double blind, controlled comparison of metoclopramide and pethidine in the emergency treatment of acute primary vascular and tension type headache episodes
Emerg. Med. J., May 1, 2004; 21(3): 323 - 326.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
K.M.A. Welch
Drug Therapy of Migraine
N. Engl. J. Med., November 11, 1993; 329(20): 1476 - 1483.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.